Evidence map›Paper›PMID 22433954›Full record

ArticleCell cycle (Georgetown, Tex.)2012

Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cancer cells.

Deborah Wilsker, Jon H Chung, Fred Bunz

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Pathways to chromothripsis.Cell cycle (Georgetown, Tex.) · 2015
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Deborah WilskerMolecular Radiation Therapeutics Branch, National Cancer Institute, Frederick, MD, USA.
Jon H Chung
Fred Bunz
Frederick Community College · USSidney Kimmel Comprehensive Cancer Center · USUniversity of Baltimore · US

Funding

Targeting the ATR pathway in p53-deficient cancersR01CA157535 · NCI · JOHNS HOPKINS UNIVERSITY · PI BUNZ, FRED · 2011 to 2015
$1.7M
Chk1 and Chk2 in Human Cancer CellsF32CA119724 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILSKER, DEBORAH F · 2006 to 2009
$146k
NCI NIH HHS F32 CA119724NCI NIH HHS F32CA119724NCI NIH HHS R01 CA157535NCI NIH HHS R01CA157535
6 · The paper itself

Abstract

Many cancer cells are unable to maintain a numerically stable chromosome complement. It is well established that aberrant cell division can generate progeny with increased ploidy, but the genetic factors required for maintenance of diploidy are not well understood. Using an isogenic model system derived by gene targeting, we examined the role of Chk1 in p53-proficient and -deficient cancer cells. Targeted inactivation of a single CHK1 allele in stably diploid cells caused an elevated frequency of mitotic bypass if p53 was naturally mutated or experimentally disrupted by homologous recombination. CHK1-haploinsufficient, p53-deficient cells frequently underwent sequential rounds of DNA synthesis without an intervening mitosis. These aberrant cell cycles resulted in whole-genome endoreduplication and tetraploidization. The unscheduled bypass of mitosis could be suppressed by targeted reversion of a p53 mutation or by exogenous expression of Cdk1. In contrast, the number of tetraploid cells was not increased in isogenic cell populations that harbor hypomorphic ATR mutations, suggesting that suppression of unscheduled mitotic bypass is a distinct function of Chk1. These results are consistent with a recently described role for Chk1 in promoting the expression of genes that promote cell cycle transitions and demonstrate how Chk1 might prevent tetraploidization during the cancer cell cycle.

Indexed as

MitosisAllelesAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell Line, TumorCheckpoint Kinase 1DiploidyDNA DamageHaploinsufficiencyHCT116 CellsHomologous RecombinationHumansMetaphaseMutationProtein KinasesProtein Serine-Threonine KinasesAtaxia Telangiectasia Mutated ProteinsATR protein, humanCell Cycle ProteinsCheckpoint Kinase 1CHEK1 protein, humanProtein KinasesProtein Serine-Threonine KinasesTumor Suppressor Protein p53

Identifiers

PMID22433954
PMCPMC3341228
OpenAlexW2023384448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.